Company / SG&A per Share
United Therapeutics SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$16.86
FY2025
5-year range
$10.36 / $16.86
FY2021-FY2025
Trend
+11.7%
vs FY2024
Sector context
#7 of 210
Health Care
What the data says
Among 210 Health Care companies, United Therapeutics is in the bottom 3% for sg&a per share. SG&A per Share has fluctuated over the past 8 years, ranging from $6.15 in FY2018 to $16.86 in FY2025.
Based on SEC 10-K filings.
16.86 in FY2025 with a 3-year CAGR of +16.4%. Top quartile in the Health Care sector.
Increased from $10.36 to $16.86 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +16.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 210This company $16.86 Sector average $40.75
▼
-58.6% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 11.7% year-over-year.
- Ranks #7 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.86 | +11.7% |
| FY2024 | $15.09 | +45.6% |
| FY2023 | $10.36 | -3.0% |
| FY2022 | $10.69 | +1.9% |
| FY2021 | $10.49 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $6.15 | -41.7% |
| FY2017 | $10.54 | +52.2% |
| FY2016 | $6.92 | -28.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026